IMPLANT SITE ERYTHEMA

This adverse event was reported 1037 times

These drugs are most commonly taken by patients reporting IMPLANT SITE ERYTHEMA:

# Drug Count
0 ETONOGESTREL 747
1 BACLOFEN 46
2 BACLOFEN INJECTION 17
3 HISTRELIN ACETATE 16
4 TESTOSTERONE 15
5 IBUPROFEN 12
6 METFORMIN 10
7 METFORMIN ER 500 MG 10
8 METFORMIN ER 750 MG 10
9 OMEPRAZOLE MAGNESIUM 10
See all common drugs associated with IMPLANT SITE ERYTHEMA

IMPLANT SITE ERYTHEMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Progestin [EPC] 747 0.0026
1 gamma-Aminobutyric Acid-ergic Agonist [EPC] 60 0.0007
2 Androgen [EPC] 15 0.0005
3 Antiseptic [EPC] 2 0.0005
4 Bismuth [EPC] 1 0.0002
5 Amide Local Anesthetic [EPC] 14 0.0002
6 Thyroid Hormone Synthesis Inhibitor [EPC] 1 0.0001
7 Barbiturate [EPC] 1 0.0001
8 Ester Local Anesthetic [EPC] 4 0.0001
9 Potassium-sparing Diuretic [EPC] 1 0.0001
See all drug classes enriched for association with IMPLANT SITE ERYTHEMA